Market revenue in 2020 | USD 763.8 million |
Market revenue in 2028 | USD 1,038.9 million |
Growth rate | 3.9% (CAGR from 2020 to 2028) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2016 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Consumables, Services |
Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Koninklijke Philips NV, BD, BioMerieux SA, Bio-Rad Laboratories Inc, QuidelOrtho Corp, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV, Roche |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious respiratory disease diagnostics market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 64.35% in 2024. Horizon Databook has segmented the Canada infectious respiratory disease diagnostics market based on instruments, consumables, services covering the revenue growth of each sub-segment from 2018 to 2030.
Canada is a rapidly developing market for infectious respiratory diseases. According to the Canada.ca, total cases of COVID-19 account for 1.5 million as of September 2021. Incidence of infectious diseases is also increasing in the region owing to seasonal influenza and COVID-19 outbreak.
To address the increased demand, manufacturers are introducing COVID-19 diagnostic products in the country that may contribute to market growth. For instance, in May 2021, Quidel Corporation received the approval for Sofia SARS Antigen FIA test from Health Canada.
Sofia SARS Antigen FIA test is used with the Sofia & Sofia 2 instruments for the detection of nucleocapsid protein antigen of SARS-CoV-2 by nasal swab specimens. Public Health Agency of Canada, National Molecular Microbiology Diagnostics User Group, and Canadian Public Health Association are actively involved in generating awareness about target diseases and providing pertinent diagnostic support.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada infectious respiratory disease diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Canada infectious respiratory disease diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account